Getinge AB (publ) (GNGBF)
USD 15.68
(0.0%)
USD 15.68
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.41 Billion SEK | -3.17% |
| 2022 | 2.49 Billion SEK | -16.13% |
| 2021 | 2.97 Billion SEK | -8.31% |
| 2020 | 3.23 Billion SEK | 165.06% |
| 2019 | 1.22 Billion SEK | 226.37% |
| 2018 | -967 Million SEK | -170.28% |
| 2017 | 1.37 Billion SEK | 15.82% |
| 2016 | 1.18 Billion SEK | -14.53% |
| 2015 | 1.39 Billion SEK | -3.0% |
| 2014 | 1.43 Billion SEK | -37.29% |
| 2013 | 2.28 Billion SEK | -9.36% |
| 2012 | 2.52 Billion SEK | -0.32% |
| 2011 | 2.52 Billion SEK | 11.07% |
| 2010 | 2.27 Billion SEK | 19.15% |
| 2009 | 1.91 Billion SEK | 25.39% |
| 2008 | 1.52 Billion SEK | 23.6% |
| 2007 | 1.23 Billion SEK | -1.67% |
| 2006 | 1.25 Billion SEK | 10.15% |
| 2005 | 1.13 Billion SEK | -0.82% |
| 2004 | 1.14 Billion SEK | 47.59% |
| 2003 | 777.7 Million SEK | 25.09% |
| 2002 | 621.7 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 513 Million SEK | 11.76% |
| 2024 Q1 | 459 Million SEK | -35.98% |
| 2024 Q3 | 2 Million SEK | -99.61% |
| 2023 Q2 | 214 Million SEK | -63.48% |
| 2023 Q1 | 586 Million SEK | 5.4% |
| 2023 Q4 | 717 Million SEK | -19.8% |
| 2023 Q3 | 894 Million SEK | 317.76% |
| 2023 FY | 2.41 Billion SEK | -3.17% |
| 2022 Q1 | 534 Million SEK | -30.83% |
| 2022 Q4 | 556 Million SEK | -30.33% |
| 2022 FY | 2.49 Billion SEK | -16.13% |
| 2022 Q3 | 798 Million SEK | 32.34% |
| 2022 Q2 | 603 Million SEK | 12.92% |
| 2021 Q4 | 772 Million SEK | 1.98% |
| 2021 FY | 2.97 Billion SEK | -8.31% |
| 2021 Q3 | 757 Million SEK | -5.14% |
| 2021 Q2 | 798 Million SEK | 23.91% |
| 2021 Q1 | 644 Million SEK | -41.13% |
| 2020 Q4 | 1.09 Billion SEK | -20.72% |
| 2020 Q2 | 494 Million SEK | 82.29% |
| 2020 Q1 | 271 Million SEK | -70.06% |
| 2020 FY | 3.23 Billion SEK | 165.06% |
| 2020 Q3 | 1.38 Billion SEK | 179.35% |
| 2019 Q3 | 208 Million SEK | 101.94% |
| 2019 Q4 | 905 Million SEK | 335.1% |
| 2019 Q1 | 6 Million SEK | -99.16% |
| 2019 Q2 | 103 Million SEK | 1616.67% |
| 2019 FY | 1.22 Billion SEK | 226.37% |
| 2018 Q3 | -1.45 Billion SEK | -1895.06% |
| 2018 Q2 | 81 Million SEK | 126.38% |
| 2018 Q1 | -307 Million SEK | -129.32% |
| 2018 FY | -967 Million SEK | -170.28% |
| 2018 Q4 | 713 Million SEK | 149.04% |
| 2017 Q3 | 50 Million SEK | 2400.0% |
| 2017 FY | 1.37 Billion SEK | 15.82% |
| 2017 Q4 | 1.04 Billion SEK | 1994.0% |
| 2017 Q1 | 277 Million SEK | -70.63% |
| 2017 Q2 | 2 Million SEK | -99.28% |
| 2016 Q3 | -86 Million SEK | -138.91% |
| 2016 Q4 | 943 Million SEK | 1196.51% |
| 2016 FY | 1.18 Billion SEK | -14.53% |
| 2016 Q2 | 221 Million SEK | 100.91% |
| 2016 Q1 | 110 Million SEK | -88.52% |
| 2015 FY | 1.39 Billion SEK | -3.0% |
| 2015 Q4 | 958 Million SEK | 453.76% |
| 2015 Q3 | 173 Million SEK | 1.76% |
| 2015 Q2 | 170 Million SEK | 88.89% |
| 2015 Q1 | 90 Million SEK | -90.97% |
| 2014 FY | 1.43 Billion SEK | -37.29% |
| 2014 Q2 | 397 Million SEK | 219.94% |
| 2014 Q1 | -331 Million SEK | -126.78% |
| 2014 Q4 | 997 Million SEK | 172.4% |
| 2014 Q3 | 366 Million SEK | -7.81% |
| 2013 FY | 2.28 Billion SEK | -9.36% |
| 2013 Q4 | 1.23 Billion SEK | 199.27% |
| 2013 Q3 | 413 Million SEK | -9.23% |
| 2013 Q2 | 455 Million SEK | 150.0% |
| 2013 Q1 | 182 Million SEK | -82.77% |
| 2012 Q4 | 1.05 Billion SEK | 103.86% |
| 2012 Q1 | 420 Million SEK | -62.47% |
| 2012 Q2 | 529 Million SEK | 25.95% |
| 2012 FY | 2.52 Billion SEK | -0.32% |
| 2012 Q3 | 518 Million SEK | -2.08% |
| 2011 Q4 | 1.11 Billion SEK | 119.41% |
| 2011 FY | 2.52 Billion SEK | 11.07% |
| 2011 Q1 | 416 Million SEK | -53.47% |
| 2011 Q2 | 483 Million SEK | 16.11% |
| 2011 Q3 | 510 Million SEK | 5.59% |
| 2010 Q3 | 496 Million SEK | 1.85% |
| 2010 Q2 | 487 Million SEK | 21.75% |
| 2010 Q1 | 400 Million SEK | -49.24% |
| 2010 FY | 2.27 Billion SEK | 19.15% |
| 2010 Q4 | 894 Million SEK | 80.24% |
| 2009 Q2 | 330 Million SEK | -13.61% |
| 2009 FY | 1.91 Billion SEK | 25.39% |
| 2009 Q1 | 382 Million SEK | 0.0% |
| 2009 Q4 | 788 Million SEK | 92.67% |
| 2009 Q3 | 409 Million SEK | 23.94% |
| 2008 FY | 1.52 Billion SEK | 23.6% |
| 2007 FY | 1.23 Billion SEK | -1.67% |
| 2006 FY | 1.25 Billion SEK | 10.15% |
| 2005 FY | 1.13 Billion SEK | -0.82% |
| 2004 FY | 1.14 Billion SEK | 47.59% |
| 2003 FY | 777.7 Million SEK | 25.09% |
| 2002 FY | 621.7 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AVITA Medical, Inc. | -39.16 Million USD | 6258.054% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 207138.627% |
| Össur hf. | 58.38 Million USD | -4030.915% |
| QHSLab, Inc. | -468.36 Thousand USD | 515086.271% |
| Wellstar International, Inc. | -3.1 Million USD | 77694.493% |
| Össur hf. | 58.38 Million USD | -4030.915% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | -125.26 Thousand USD | 1925679.39% |
| Aurora Spine Corporation | -1.68 Million USD | 143623.331% |
| BrainsWay Ltd. | -4.19 Million USD | 57569.621% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | 333796.729% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 397449.684% |
| Vivos Inc. | -2.89 Million USD | 83423.171% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | 1104136.691% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 135770.404% |
| Zecotek Photonics Inc. | -3.51 Million USD | 68642.57% |
| Avitar, Inc. | -2.25 Million USD | 106843.187% |
| Nanomix Corporation | -12.33 Million USD | 19657.323% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | -102451.02% |
| Theraclion SA | -3.67 Million USD | 65732.564% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.63 Million USD | 147289.576% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 91420.536% |
| Lombard Medical, Inc. | -31.03 Million USD | 7871.87% |
| ALR Technologies Inc. | -11.89 Million USD | 20374.595% |
| Stratec SE | 14.42 Million USD | -16619.903% |
| Vycor Medical, Inc. | -69.69 Thousand USD | 3461092.094% |
| Heart Tronics, Inc. | -13.32 Million USD | 18198.377% |
| MicroPort Scientific Corporation | -477.62 Million USD | 604.994% |
| VMS Rehab Systems, Inc. | 46.44 USD | -5193798349.612% |
| NewCardio, Inc. | -11.49 Million USD | 21080.742% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 69231.556% |
| Ingen Technologies, Inc. | -5.06 Million USD | 47754.027% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 266392.473% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 577087.941% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 320426.808% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 9446.301% |
| IR-Med Inc. | -4.9 Million USD | 49234.243% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 17284.39% |
| Polarean Imaging plc | -11.88 Million USD | 20394.825% |
| United American Healthcare Corporation | 723 Thousand USD | -333509.959% |
| ECGI Holdings, Inc. | -3.61 Million USD | 66897.862% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | 1921614.268% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 366651.98% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 336571.596% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | -610780.357% |
| Urologix, Inc. | -7.6 Million USD | 31803.47% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 142501.532% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 110862.059% |
| SS Innovations International, Inc. | -20.94 Million USD | 11617.54% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 299719.513% |
| Smith & Nephew plc | 263 Million USD | -817.11% |
| NIOX Group Plc | 13.64 Million USD | -17582.666% |
| Fuse Medical, Inc. | 1.45 Million USD | -165109.553% |
| Broncus Holding Corporation | -28.09 Million USD | 8686.38% |
| Brain Scientific Inc. | -12.34 Million USD | 19640.082% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 8328.067% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | 1505266.991% |